This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
North China Pharmaceutical Company.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
North China Pharmaceutical Company.Ltd agreed to acquire the remaining 35.85% stake in NCPC Hebei Huamin Pharmaceutical Co., Ltd. from CCB Financial Asset Investment Co., Ltd. for CNY 670 million CI
North China Pharmaceutical Company.Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
North China Pharmaceutical Subsidiary Gets Europe's Compliance Certification for Drug Raw Material MT
Jizhong Energy Group Finance Co., Ltd announced that it has received CNY 1.3 billion in funding from Jizhong Energy Group Co.,Ltd., Jizhong Energy Resources Co., Ltd., North China Pharmaceutical Company.Ltd CI
North China Pharmaceutical Gets Nod to Market Ampicillin API MT
North China Pharmaceutical Company.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
North China Pharmaceutical Company.Ltd(XSSC:600812) added to S&P Global BMI Index CI
North China Pharmaceutical Company.Ltd(XSSC:600812) added to FTSE All-World Index CI
North China Pharmaceutical Company.Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Jizhong Energy Group Finance Co., Ltd announced that it expects to receive CNY 1.3 billion in funding from Jizhong Energy Group Co.,Ltd., Jizhong Energy Resources Co., Ltd., North China Pharmaceutical Company.Ltd CI
North China Pharmaceutical Company Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
North China Pharma Unit Passes Compliance Inspection MT
North China Pharmaceutical's Heart Drug Passes Regulatory Evaluation MT
North China Pharmaceutical Company Ltd.(SHSE:600812) dropped from Shanghai Stock Exchange Health Care Sector Index CI
North China Pharmaceutical Company Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
North China Pharmaceutical Company Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
North China Pharmaceutical Company Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
China Rolls Out New Rules to Fight Monopoly in API Drugmaking Market MT
North China Pharmaceutical Company Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
North China Pharmaceutical Company Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Chinese vitamin C price-fixing lawsuit thrown out by U.S. appeals court RE
North China Pharmaceutical Company Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
North China Pharmaceutical Company Ltd. announced a financing transaction CI
North China Pharmaceutical Company. Ltd completed the acquisition of North China Pharmaceutical Group Corporation Veterinary Co., Ltd., from North China Pharmaceutical Group Corp. CI
Chart North China Pharmaceutical Company.Ltd
More charts
North China Pharmaceutical Co Ltd is a China-based company primarily engaged in the research, development, production and sales of pharmaceutical products. The Company's main products include anti-infective drugs, nephrology and immunomodulatory drugs, biotechnology drugs, cardiovascular and cerebrovascular and immunomodulatory agents, vitamins and health consumer products, nervous and blood system drugs, pharmaceutical intermediates, anti-epidemic drugs, pesticides and Veterinary drugs. The Company is also engaged in pharmaceutical and other logistics trade pharmaceuticals. The Company's products are mainly used in chemical pharmaceuticals, modern biotechnology drugs, vitamins and health consumer products, bioagricultural and veterinary drugs and other fields. The Company mainly conducts its businesses in domestic and overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. 600812 Stock
  4. News North China Pharmaceutical Company.Ltd
  5. North China Pharma Unit Passes Compliance Inspection
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW